Abstract
Serotonin (5-HT)is involved in various physiological and pathological processes by interaction with 14 distinct receptor subtypes,grouped in seven classes of receptors (5-HT 1-7 )on the basis of amino acid sequence,pharmacology,and signal transduction pathways.The 5-HT 7 R is a G-protein coupled receptor with seven transmembrane domains.It was found by the application of molecular cloning and has been identified in rat,mouse,human,pig,and guinea pig.Although the biological functions of the 5-HT 7 Rs are poorly understood,preliminary evidence suggests that it may be involved in depression,control of circadian rhythms,and relaxation of vascular smooth muscles.For these reasons,the 5-HT 7 R has become a target for the development of novel drugs.This review will give a brief introduction of the pharmacology of 5-HT 7 R (molecular structure,distribution of 5- HT 7 R mRNA,localization of the 5-HT 7 R protein,functional correlates,and therapeutic potential)and a detailed survey of the 5-HT 7 R ligands,which have appeared in the literature in both papers and patents.Structure- activity relationships (SAR)of these ligands will also be described.
Keywords: Serotonin7 Receptors, amino acid
Current Medicinal Chemistry
Title: Serotonin7 Receptors (5-HT7Rs)and their Ligands
Volume: 11 Issue: 5
Author(s): M. Leopoldo
Affiliation:
- Universita degli Studi di Bari,Dipartimento Farmaco-Chimico,via Orabona,4,70125,Bari,Italy.,Italy
Keywords: Serotonin7 Receptors, amino acid
Abstract: Serotonin (5-HT)is involved in various physiological and pathological processes by interaction with 14 distinct receptor subtypes,grouped in seven classes of receptors (5-HT 1-7 )on the basis of amino acid sequence,pharmacology,and signal transduction pathways.The 5-HT 7 R is a G-protein coupled receptor with seven transmembrane domains.It was found by the application of molecular cloning and has been identified in rat,mouse,human,pig,and guinea pig.Although the biological functions of the 5-HT 7 Rs are poorly understood,preliminary evidence suggests that it may be involved in depression,control of circadian rhythms,and relaxation of vascular smooth muscles.For these reasons,the 5-HT 7 R has become a target for the development of novel drugs.This review will give a brief introduction of the pharmacology of 5-HT 7 R (molecular structure,distribution of 5- HT 7 R mRNA,localization of the 5-HT 7 R protein,functional correlates,and therapeutic potential)and a detailed survey of the 5-HT 7 R ligands,which have appeared in the literature in both papers and patents.Structure- activity relationships (SAR)of these ligands will also be described.
Export Options
About this article
Cite this article as:
Leopoldo M., Serotonin7 Receptors (5-HT7Rs)and their Ligands, Current Medicinal Chemistry 2004; 11(5) . https://dx.doi.org/10.2174/0929867043455828
| DOI https://dx.doi.org/10.2174/0929867043455828 |
Print ISSN 0929-8673 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Allegations from Whistleblowers
- Publishing Ethics
- Increase Visibility Of Your Article
- Self Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 1: General Overview with a Focus on Ascorbic Acid
Inflammation & Allergy - Drug Targets (Discontinued) Somatic Genome Variations in Health and Disease
Current Genomics Message from the Editor-in-Chief
CNS & Neurological Disorders - Drug Targets Long-term Treatment with Olanzapine Increases the Number of Sox2 and Doublecortin Expressing Cells in the Adult Subventricular Zone
CNS & Neurological Disorders - Drug Targets The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells
Current Pharmaceutical Design Genetics and Personalized Medicine in Antidepressant Treatment
Current Pharmaceutical Design Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions
Current Molecular Pharmacology Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Medicinal Agents and Metabolic Syndrome
Current Medicinal Chemistry Commentary Research Highlights: Adaptive PTEN Loss Enhances the Outgrowth of Brain Metastatic Tumour Cells
CNS & Neurological Disorders - Drug Targets The Role of Minocycline in Ischemia-Reperfusion Injury: A Comprehensive Review of an Old Drug with New Implications
Recent Patents on Cardiovascular Drug Discovery Antipsychotic and Antiepileptic Drugs in Bipolar Disorder: The Importance of Therapeutic Drug Monitoring
Current Medicinal Chemistry Identification of a Pathogenic PSEN1 Ala285Val Mutation Associated with Early-Onset Alzheimer’s Disease
Current Alzheimer Research Editorial: Brain Basis of Resilience and its Effect on Mood Disorders in the Aging
Current Neuropharmacology Actions of the Anti-Angiogenic Compound Angiostatin in an Animal Model of Alzheimer’s Disease
Current Alzheimer Research Meet Our Editorial Board Member
Current Alzheimer Research Cognitive Rehabilitation for Schizophrenia: A Review of Recent Advances
Current Psychiatry Reviews Therapeutic Potential of Targeting the Endocannabinoids: Implications for the Treatment of Obesity, Metabolic Syndrome, Drug Abuse and Smoking Cessation
Current Medicinal Chemistry A Review on Recent Patents in Digital Processing for Cardiac Electric Signals (II): Advanced Systems and Applications
Recent Patents on Biomedical Engineering (Discontinued) Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences
Current Cardiology Reviews

